Live feed09:30:00·627dPRReleasevia QuantisnowAsha Therapeutics Awarded Barnett Drug Development Grant by the ALS Association to Advance Novel Intra-Molecular Glue Inhibitor of SARM1 to Clinic and Announces Appointment of Disarm Therapeutics' Founders to Company's Scientific Advisory BoardByQuantisnow·Wall Street's wire, on your screen.LLY· Eli Lilly and CompanyHealth Care